Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.

× No keyword cloud information.

22 in total

1. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes.

Authors: H F Furneaux; L Reich; J B Posner
Journal: Neurology Date: 1990-07 Impact factor: 9.910

2. Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes.

Authors: F Graus; J Abos; J Roquer; R Mazzara; A Pereira
Journal: Neurology Date: 1990-10 Impact factor: 9.910

3. Subacute cerebellar degeneration associated with neoplasms.

Authors: L Brain; M Wilkinson
Journal: Brain Date: 1965-09 Impact factor: 13.501

4. Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system.

Authors: J W Moll; S C Henzen-Logmans; T A Splinter; M E van der Burg; C J Vecht
Journal: J Neurol Neurosurg Psychiatry Date: 1990-11 Impact factor: 10.154

5. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.

Authors: N E Anderson; M K Rosenblum; F Graus; R G Wiley; J B Posner
Journal: Neurology Date: 1988-09 Impact factor: 9.910

6. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration.

Authors: J Cunningham; F Graus; N Anderson; J B Posner
Journal: Neurology Date: 1986-09 Impact factor: 9.910

7. Ovarian carcinoma and paraneoplastic cerebellar degeneration.

Authors: R McLellan; J L Currie; W Royal; N B Rosenshein
Journal: Obstet Gynecol Date: 1988-12 Impact factor: 7.661

8. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.

Authors: J E Greenlee; H R Brashear
Journal: Ann Neurol Date: 1983-12 Impact factor: 10.422

Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.